Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
2.96
+0.06 (2.25%)
Sep 29, 2023, 9:57 AM EDT - Market open
Standard BioTools Stock Forecast
Stock Price Forecast
According to 1 stock analyst, the 12-month stock price forecast for LAB stock stock is $4.00, which predicts an increase of 35.36%. On average, analysts rate LAB stock stock as a buy.
Analyst Consensus: Buy
* Price targets were last updated on Jul 12, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for LAB is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '23 | Sep '23 |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Initiates $4 | Buy | Initiates | $4 | +35.36% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
101.91M
from 97.95M
Increased by 4.05%
Revenue Next Year
119.58M
from 101.91M
Increased by 17.34%
EPS This Year
-0.45
from -2.43
EPS Next Year
-0.25
from -0.45
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 106.0M | 124.3M | 151.6M |
| Avg | 101.9M | 119.6M | 145.8M |
| Low | 98.9M | 116.0M | 141.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 8.2% | 22.0% | 26.8% |
| Avg | 4.0% | 17.3% | 22.0% |
| Low | 1.0% | 13.9% | 18.3% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -0.47 | -0.26 | 0.01 |
| Avg | -0.45 | -0.25 | 0.01 |
| Low | -0.44 | -0.25 | 0.01 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.